BOSENTAN ZENTIVA 62.5mg tablets medication leaflet

C02KX01 bosentan • Cardiovascular system | Other antihypertensives | Antihypertensives for pulmonary arterial hypertension

Bosentanum is a medication used for the treatment of pulmonary arterial hypertension (PAH), a condition characterized by increased pressure in the pulmonary arteries. It is an endothelin receptor antagonist that helps relax blood vessels and reduce blood pressure.

The medication is taken orally, usually twice daily, as directed by a doctor. The treatment requires regular monitoring, including blood tests to assess liver function.

Common side effects include headaches, edema, fatigue, and elevated liver enzyme levels. In rare cases, more severe adverse effects such as liver failure or anemia may occur.

Bosentanum is not recommended for pregnant women, as it may cause birth defects. Patients should use effective contraception during treatment and inform their doctor about any other medications they are taking to avoid drug interactions.

General data about BOSENTAN ZENTIVA 62.5mg

Substance: bosentan

Date of last drug list: 01-04-2014

Commercial code: W60339006

Concentration: 62.5mg

Pharmaceutical form: tablets

Quantity: 112

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for bosentan

125mg, 62.5mg